|
注册号: Registration number: |
ChiCTR2600116908 |
|
最近更新日期: Date of Last Refreshed on: |
2026-01-16 11:32:40 |
|
注册时间: Date of Registration: |
2026-01-16 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
5W传播模式结合KSA模型在护士健康传播能力提升中的应用 |
|
Public title: |
The application of the 5W communication model combined with the KSA model in enhancing the health communication capabilities of nurses |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
5W传播模式结合KSA模型在护士健康传播能力提升中的应用 |
|
Scientific title: |
The application of the 5W communication model combined with the KSA model in enhancing the health communication capabilities of nurses |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
张晓翠 |
研究负责人: |
张晓翠 |
|
Applicant: |
Zhang Xiaocui |
Study leader: |
Zhang Xiaocui |
|
申请注册联系人电话: Applicant telephone: |
+86 318 311 9066 |
研究负责人电话:
Study leader's |
+86 318 311 9066 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
1072617207@qq.com |
研究负责人电子邮件: Study leader's E-mail: |
1072617207@qq.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
河北省深州市永平大街83号 |
研究负责人通讯地址: |
河北省深州市永平大街83号 |
|
Applicant address: |
No. 83 Yongping Street, Shenzhou City, Hebei Province |
Study leader's address: |
No. 83 Yongping Street, Shenzhou City, Hebei Province |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
河北省深州市医院 |
||
|
Applicant's institution: |
Shenzhou Hospital, Hebei Province |
||
|
研究负责人所在单位: |
河北省深州市医院 |
||
|
Affiliation of the Leader: |
Shenzhou Hospital, Hebei Province |
||
|
是否获伦理委员会批准: |
是 |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
LW2024-002 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
河北省深州市医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of Shenzhou City Hospital, Hebei Province |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-12-15 00:00:00 | ||
|
伦理委员会联系人: |
聂紫星 |
||
|
Contact Name of the ethic committee: |
Nie Zixing |
||
|
伦理委员会联系地址: |
河北省深州市永平大街83号 |
||
|
Contact Address of the ethic committee: |
No. 83 Yongping Street, Shenzhou City, Hebei Province |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 137 8028 2999 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
河北省深州市医院 |
||||||||||||||||||||||
|
Primary sponsor: |
Shenzhou Hospital, Hebei Province |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
河北省深州市永平大街83号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
No. 83 Yongping Street, Shenzhou City, Hebei Province |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
自选课题(自筹) |
||||||||||||||||||||||
|
Source(s) of funding: |
Self-selected topic (self-funded) |
||||||||||||||||||||||
|
研究疾病: |
无 |
||||||||||||||||||||||
|
Target disease: |
None |
||||||||||||||||||||||
|
研究疾病代码: |
|
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
干预性研究 |
||||||||||||||||||||||
|
Study type: |
Interventional study |
||||||||||||||||||||||
|
研究所处阶段: |
其它 | ||||||||||||||||||||||
|
Study phase: |
N/A |
||||||||||||||||||||||
|
研究设计: |
非随机对照试验 |
||||||||||||||||||||||
|
Study design: |
Non randomized control |
||||||||||||||||||||||
|
研究目的: |
调查护士健康素养传播能力水平现状,并分析影响因素,以此为依据,护理管理者形成针对性干预方案,提升护士健康素养传播能力。 |
||||||||||||||||||||||
|
Objectives of Study: |
Investigate the current status of nurses' health literacy communication competence, analyze the influencing factors, and on this basis, nursing managers formulate targeted intervention plans to improve nurses' health literacy communication competence. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
|
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
|
||||||||||||||||||||||
|
纳入标准: |
|||||||||||||||||||||||
|
Inclusion criteria |
|||||||||||||||||||||||
|
排除标准: |
第一阶段(横断面研究): 进修、休假等无法完成调查者 第二、三阶段(干预性研究): 1.个体层面:目前正参与其他可能影响本研究主要结局指标的干预性研究。 2.科室层面: 所在科室在过去6个月内已系统开展过同类结构化健康传播培训。 所在科室在未来3个月内有重大调整计划(如搬迁、合并等变更)。 |
||||||||||||||||||||||
|
Exclusion criteria: |
Phase 1 (Cross-sectional Study): Those who were unable to complete the survey due to, vacation, etc. Phase 2 and 3 (Interventional Studies): 1. At the individual level: Currently participating in other intervention studies that may affect the main outcome indicators of this study. 2. At the department level: The department where the subject works has systematically conducted similar structured health communication training in the past 6 months. The department where the subject works has major adjustment plans (such as relocation, merger, etc.) in the next 3 months. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2026-01-16 00:00:00至 To 2027-05-01 00:00:00 |
征募观察对象时间: Recruiting time: |
从 From 2026-01-16 00:00:00 至 To 2026-05-01 00:00:00 |
|
干预措施: Interventions: |
|
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
无 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
None |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
None |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
否No |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
无 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
None |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
CRF |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
CRF |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
暂未确定/Not yet |